News
Market
Jobs
About
Contact
List Product
Register
Login
Generate
WhatsApp Message
*Zimbabwe Records 1122 New COVID-19 Recoveries In One Day* *Follow Pindula on WhatsApp for daily new updates* https://whatsapp.com/channel/0029Va84dngJP21B2nWeyM3v?ng Yesterday Zimbabwe recorded 1122 COVID-19 recoveries which since the onset of the pandemic was the first highest recovery rate to date. The 95% recovery rate was contained in a Ministry of Health and Child Care’s daily update which stated that active cases have dropped to below 200 for the first time in months. The Ministry of Health said: ---------- *HOT DEALS:* *itel A70 - (128GB, 3GB RAM) $89,* *itel A70 - (256GB, 4GB RAM) $99* *itel P40 (128GB, 4GB), (6000mAh) $99* *itel P40 (64GB, 4G), (6000mAh) $93* *LATEST: itel S24 (128) $124; S24 (256GB) $159* Cash on Delivery in Harare & Bulawayo. Tinotumira kwamuri inosvika. WhatsApp: 0️⃣7️⃣8️⃣3️⃣ 4️⃣5️⃣0️⃣ 7️⃣9️⃣3️⃣ ---------- > 481 Polymerous Chain Reaction (PCR) tests done today (positivity was 2.1%). 1122 new recoveries were reported while the national recovery rate rises to 95% and active cases go down to 164 today. Of the 1122 recoveries recorded yesterday, 1114 of them were recorded in Harare according to Health Times. According to World Health: > WHO has published guidance on adjusting public health and social measures for the next phase of the COVID-19 response. Some governments have suggested that the detection of antibodies to the SARS-CoV-2, the virus that causes COVID-19, could serve as the basis for an “immunity passport” or “risk-free certificate” that would enable individuals to travel or to return to work assuming that they are protected against re-infection. There is currently no evidence that people who have recovered from COVID-19 and have antibodies are protected from a second infection. > Many countries are now testing for SARS-CoV-2 antibodies at the population level or in specific groups, such as health workers, close contacts of known cases, or within households. WHO supports these studies, as they are critical for understanding the extent of – and risk factors associated with – infection. These studies will provide data on the percentage of people with detectable COVID-19 antibodies, but most are not designed to determine whether those people are immune to secondary infections. More: Health Times _If you found this article useful_ *Please support Pindula by forwarding to friends and groups*
Copy to clipboard
Give us Feedback
Full Name
WhatsApp Number
Feedback
Submit
Feedback